Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Company profile
Ticker
TKPHF
Exchange
Website
CEO
Christophe Weber
Employees
Location
Sector
SEC CIK
Calendar
25 May 22
Institutional ownership, Q1 2022
3.5% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 272 |
| Opened positions | 43 |
| Closed positions | 58 |
| Increased positions | 90 |
| Reduced positions | 68 |
| 13F shares | Current |
|---|---|
| Total value | 1.14B |
| Total shares | 55.96M |
| Total puts | 333.4K |
| Total calls | 2.17M |
| Total put/call ratio | 0.2 |
| Largest owners | Shares | Value |
|---|---|---|
| Mondrian Investment Partners | 4.32M | $60.48M |
| Parametric Portfolio Associates | 4.26M | $60.95M |
| GS Goldman Sachs | 4.24M | $60.76M |
| MCQEF Macquarie | 4.22M | $60.45M |
| BAC Bank Of America | 3.39M | $48.52M |
| BLK Blackrock | 3.02M | $43.27M |
| FMR | 2.45M | $35.06M |
| NTRS Northern Trust | 2.22M | $31.78M |
| Brandes Investment Partners | 2.11M | $30.21M |
| Renaissance Technologies | 1.99M | $28.54M |
Financial report summary
?Financial reports
No filings
Current reports
No filings
Registration and prospectus
Proxies
No filings